Evidence map›Paper›PMID 31728271›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Gene Delivery to Nonhuman Primate Preimplantation Embryos Using Recombinant Adeno-Associated Virus.

Dan Wang, Yuyu Niu, Lingzhi Ren, Yu Kang, Phillip W L Tai, Chenyang Si, Craig A Mendonca, Hong Ma, Guangping Gao, Weizhi Ji

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. One-stepFrontiers in cell and developmental biology · 2024
    Article
  3. Article
  4. Germline stem cells in human.Signal transduction and targeted therapy · 2022
    Review
  5. Article
  6. Recent Advances in the Production of Genome-Edited Rats.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Dan WangHorae Gene Therapy Center University of Massachusetts Medical School Worcester MA 01605 USA.ORCID https://orcid.org/0000-0001-9079-2360
Yuyu NiuYunnan Key Laboratory of Primate Biomedicine Research Institute of Primate Translational Medicine Kunming University of Science and Technology Kunming 650500 Yunnan China.
Lingzhi RenHorae Gene Therapy Center University of Massachusetts Medical School Worcester MA 01605 USA.
Yu KangYunnan Key Laboratory of Primate Biomedicine Research Institute of Primate Translational Medicine Kunming University of Science and Technology Kunming 650500 Yunnan China.
Phillip W L TaiHorae Gene Therapy Center University of Massachusetts Medical School Worcester MA 01605 USA.
Chenyang SiYunnan Key Laboratory of Primate Biomedicine Research Institute of Primate Translational Medicine Kunming University of Science and Technology Kunming 650500 Yunnan China.
Craig A MendoncaHorae Gene Therapy Center University of Massachusetts Medical School Worcester MA 01605 USA.
Hong MaHorae Gene Therapy Center University of Massachusetts Medical School Worcester MA 01605 USA.
Guangping GaoHorae Gene Therapy Center University of Massachusetts Medical School Worcester MA 01605 USA.
Weizhi JiYunnan Key Laboratory of Primate Biomedicine Research Institute of Primate Translational Medicine Kunming University of Science and Technology Kunming 650500 Yunnan China.
University of Massachusetts Chan Medical School · USKunming University of Science and Technology · CN

Funding

Viral Vector CoreP01HL131471 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FLOTTE, TERENCE R. · 2016 to 2020
$11.3M
Oligodendrocyte-focused rAAV gene therapy strategies for Canavan disease and LeukodystrophiesR01NS076991 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Guangping Gao · 2012 to 2026
$5.7M
Develop combinatorial non-viral and viral CRISPR delivery for lung diseasesUG3HL147367 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ANDERSON, DANIEL G, GAO, GUANGPING · 2018 to 2020
$2.7M
NHLBI NIH HHS P01 HL131471NINDS NIH HHS R01 NS076991
6 · The paper itself

Abstract

Delivery of genome editing tools to mammalian zygotes has revolutionized animal modeling. However, the mechanical delivery method to introduce genes and proteins to zygotes remains a challenge for some animal species that are important in biomedical research. Here, an approach to achieve gene delivery and genome editing in nonhuman primate embryos is presented by infecting zygotes with recombinant adeno-associated viruses (rAAVs). Together with previous reports from the authors of this paper and others, this approach is potentially applicable to a broad range of mammals. In addition to genome editing and animal modeling, this rAAV-based method can facilitate gene function studies in early-stage embryos.

Indexed as

adeno‐associated virus (AAV)animal modelingCRISPRgenome editing

Identifiers

PMID31728271
PMCPMC6839749
OpenAlexW2971609849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.